NLRP3 and Chronic colitis: We displayed these speculations in Table 5: (1) the combination effect of the colchicine, NLRP3, comorbidities and detection bias on the risk of cancer in colorectal cancer with chronic colitis; (2) sex and age for modulating the effect of colchicine on the risk of colorectal cancer [40, 41].